The Efficiency of the GeneXpert Method Compared With Traditional Methods for Diagnosing TB

Authors

  • Korab Hoxha University of Tetovo, Department of Medicine, Tetovo, North Macedonia

DOI:

https://doi.org/10.51699/ijhsms.v3i5.166

Keywords:

Tuberculosis, Disease, Contagious, Care, Cure

Abstract

Tuberculosis (TB), caused by Mycobacterium tuberculosis, remains a significant global health concern, particularly due to its high prevalence in the lungs, accounting for approximately 70% of cases. While vaccines have alleviated the impact of TB, it remains highly contagious through airborne transmission from infected individuals. Other forms of TB, such as those affecting lymphatic glands or bones, are non-contagious. The distinction between latent TB infections and active, contagious forms highlights the importance of public health interventions. This study aims to explore the transmission dynamics, focusing on prevention strategies to mitigate airborne spread. Using a case study approach, the research analyzes infection patterns, underscores the need for vigilant contact management, and emphasizes the importance of vaccines and protective measures in preventing TB outbreaks. The findings suggest that early diagnosis and proper management can significantly reduce transmission, offering practical implications for TB control.

References

N. Ozkutuk and S. Surucüoglu, "Evaluation of the Xpert MTB/RIF Assay for the Diagnosis of Pulmonary and Extrapulmonary Tuberculosis in an Intermediate-Prevalence Setting," Mikrobiyol Bul., vol. 48, no. 2, pp. 223-232, Apr. 2014, doi: 10.5578/mb.7456. PMID: 24819260. DOI: https://doi.org/10.5578/mb.7456

D. Hillemann, S. Rüsch-Gerdes, C. Boehme, and E. Richter, "Rapid Molecular Detection of Extrapulmonary Tuberculosis by the Automated GeneXpert MTB/RIF System," J. Clin. Microbiol., vol. 49, 2011. doi: 10.1128/jcm.02268-10. DOI: https://doi.org/10.1128/JCM.02268-10

L. Balaji, L. Ramanan, M. Nandhagopal, et al., "Examining Diagnostic Efficacy: GeneXpert Versus Traditional Staining Techniques With Culture in the Diagnosis of Tuberculosis," Cureus, vol. 16, no. 7, p. e63641, Jul. 2024, doi: 10.7759/cureus.63641. DOI: https://doi.org/10.7759/cureus.63641

Z. Nadeem, J. Iqbal, S. Kausar, A. Gasmi Benahmed, S. Noor, F. S. Khan, I. Saleem, N. Munir, M. Riaz, M. Akram, P. O. Oladoye, S. A. Salim, A. A. Abed, W. F. Elbossaty, and A. Gasmi, "Comparative Analysis of the Efficacies of the GeneXpert and Solid Culture Media Techniques in the Diagnosis of Mycobacterium Tuberculosis," Arch. Razi Inst., vol. 77, no. 6, pp. 2065-2072, Dec. 2022, doi: 10.22092/ARI.2022.359856.2486. PMID: 37274882; PMCID: PMC10237581.

M. J. Kim, Y. S. Nam, S. Y. Cho, T. S. Park, and H. J. Lee, "Comparison of the Xpert MTB/RIF Assay and Real-time PCR for the Detection of Mycobacterium Tuberculosis," Ann. Clin. Lab. Sci., vol. 45, no. 3, pp. 327-332, Spring 2015. PMID: 26116598.

E. Lapteva, I. Kovalenko, O. Burakevich, O. Kharevich, E. Katibnikova, T. Yarovaya, O. Goreniuk, N. Bogushevich, A. Pozdnyakova, A. Laptev, V. Korovkin, V. Khotko, and A. Mushovets, "Diagnostic Value of GeneXpert MTB/RIF Assay for Tuberculosis Diagnosis Compared to Traditional Methods," J. Grodno State Med. Univ., vol. 21, no. 2, pp. 118-123, 2023. doi: 10.25298/2221-8785-2023-21-2-118-123. DOI: https://doi.org/10.25298/2221-8785-2023-21-2-118-123

D. Zhang, F. Yu, D. Han, W. Chen, L. Yuan, M. Xie, J. Zheng, J. Wang, B. Lou, S. Zheng, and Y. Chen, "ddPCR Provides a Sensitive Test Compared With GeneXpert MTB/RIF and mNGS for Suspected Mycobacterium Tuberculosis Infection," Front. Cell. Infect. Microbiol., vol. 13, Article 1216339, 2023. doi: 10.3389/fcimb.2023.1216339. DOI: https://doi.org/10.3389/fcimb.2023.1216339

"Procedure for Performing the Xpert MTB/RIF Test on a Clinical Sample," ResearchGate, [Online]. Available: https://www.researchgate.net/figure/Procedure-for-performing-the-Xpert-MTB-RIF-test-on-a-clinical-sample-4_fig1_383423571.

WHO, "WHO Meeting Report of a Technical Expert Consultation, Non-Inferiority Analysis of Xpert MTB/RIF Ultra Compared to Xpert MTB/RIF," 2017. [Online]. Available: http://www.who.int/tb/publications/2017/XpertUltra/en/.

S. Chakravorty, A. M. Simmons, M. Rowneki, Y. Cao, J. Ryan, P. P. Banada, "The New Xpert MTB/RIF Ultra: Improving Detection of Mycobacterium Tuberculosis and Resistance to Rifampin in an Assay Suitable for Point-of-Care Testing," mBio, vol. 8, 2017. doi: 10.1128/mBio.00812-17. DOI: https://doi.org/10.1128/mBio.00812-17

Downloads

Published

2024-10-24

How to Cite

Hoxha, K. (2024). The Efficiency of the GeneXpert Method Compared With Traditional Methods for Diagnosing TB. International Journal of Health Systems and Medical Sciences, 3(5), 322–327. https://doi.org/10.51699/ijhsms.v3i5.166

Issue

Section

Articles